Mono Pharmacare (NSE:MONOPHARMA) Equity-to-Asset : 0.28 (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Mono Pharmacare Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Mono Pharmacare's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ₹312 Mil. Mono Pharmacare's Total Assets for the quarter that ended in Mar. 2025 was ₹1,101 Mil. Therefore, Mono Pharmacare's Equity to Asset Ratio for the quarter that ended in Mar. 2025 was 0.28.

The historical rank and industry rank for Mono Pharmacare's Equity-to-Asset or its related term are showing as below:

NSE:MONOPHARMA' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21 Med: 0.3 Max: 0.35
Current: 0.28

During the past 5 years, the highest Equity to Asset Ratio of Mono Pharmacare was 0.35. The lowest was 0.21. And the median was 0.30.

NSE:MONOPHARMA's Equity-to-Asset is ranked worse than
74.78% of 686 companies
in the Healthcare Providers & Services industry
Industry Median: 0.49 vs NSE:MONOPHARMA: 0.28

Mono Pharmacare Equity-to-Asset Historical Data

The historical data trend for Mono Pharmacare's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mono Pharmacare Equity-to-Asset Chart

Mono Pharmacare Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Equity-to-Asset

0.33

0.30

0.21

0.35

0.28

Mono Pharmacare Semi-Annual Data
	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
Equity-to-Asset	Get a 7-Day Free Trial			0.21	0.37	0.35	0.31	0.28

Competitive Comparison of Mono Pharmacare's Equity-to-Asset

For the Pharmaceutical Retailers subindustry, Mono Pharmacare's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mono Pharmacare's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mono Pharmacare's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Mono Pharmacare's Equity-to-Asset falls into.

Save Embed

;

Save Embed

;

Mono Pharmacare Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Mono Pharmacare's Equity to Asset Ratio for the fiscal year that ended in Mar. 2025 is calculated as

Equity to Asset (A: Mar. 2025 )	=	Total Stockholders Equity	/	Total Assets
	=	311.992	/	1100.55
	=	0.28

Mono Pharmacare's Equity to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

Equity to Asset (Q: Mar. 2025 )	=	Total Stockholders Equity	/	Total Assets
	=	311.992	/	1100.55
	=	0.28

Mono Pharmacare (NSE:MONOPHARMA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Mono Pharmacare Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Mono Pharmacare's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Mono Pharmacare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mono Pharmacare Ltd (NSE:MONOPHARMA) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1A, Krinkal Apartment, Opp. Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007

Website

https://www.monopharmacareltd.com

Mono Pharmacare Ltd is a distributor and supplier of a wide array of Pharmaceuticals products and medicines. The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac-Diabetic medicines, and cosmocare products.

Mono Pharmacare Headlines

No Headlines